Search Results - "Burmeister, Melissa"

Refine Results
  1. 1

    Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a by Younce, Craig W, Burmeister, Melissa A, Ayala, Julio E

    “…Hyperglycemia-induced cardiomyocyte apoptosis contributes to diabetic cardiomyopathy. Glucagon-like peptide-1 (Glp1) receptor (Glp1r) agonists improve cardiac…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen by Johnson, Kennadi, Weldon, Abby J, Burmeister, Melissa A

    Published in Frontiers in psychiatry (23-04-2024)
    “…Schizophrenia is a serious mental health disorder that confers one of the highest mortality rates of all psychiatric illnesses. Although the disorder's…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Real-world community hospital hyperglycemia management in noncritically ill, type 2 diabetic patients: a comparison between basal-bolus insulin and correctional insulin by Yang, Caiyun J, Bourgeois, Chelsey, Delgado, Elina, Graham, William, Burmeister, Melissa A

    “…This study evaluated the safety and efficacy of two insulin regimens for inpatient hyperglycemia management: combination short-plus long-acting insulin…”
    Get full text
    Journal Article
  6. 6

    The pharmacist’s role in reducing infusion-related phlebitis by Johnson, Jessica L, Norton, Cory, Fryfogle, Erin, Fincher, Timothy K, Burmeister, Melissa A

    Published in American journal of health-system pharmacy (21-07-2023)
    “…Abstract Purpose Pharmacists oversee parenteral drug preparation and administration in hospitals, clinics, infusion centers, and home infusion settings…”
    Get full text
    Journal Article
  7. 7

    Evidence for proton-pump inhibitor (PPI)-associated dysbiosis in metabolically unhealthy obesity by Burmeister, Melissa A, Smith, Tara E, Fincher, Timothy K, Weldon, Abby J

    Published in Frontiers in endocrinology (Lausanne) (15-06-2023)
    “…Obesity adversely impacts millions of American adults by predisposing them to significant health risks and further complications. Obesity is differentiated…”
    Get full text
    Journal Article
  8. 8

    Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose by Burmeister, Melissa A, Ayala, Jennifer, Drucker, Daniel J, Ayala, Julio E

    “…Glucagon-like peptide-1 (GLP-1) suppresses food intake via activation of a central (i.e., brain) GLP-1 receptor (GLP-1R). Central AMP-activated protein kinase…”
    Get more information
    Journal Article
  9. 9

    Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice by Burmeister, Melissa A, Ferre, Tura, Ayala, Jennifer E, King, Emily M, Holt, Rochelle M, Ayala, Julio E

    “…Glucagon-like peptide-1 (GLP-1) receptor knockout (Glp1r(-/-)) mice exhibit impaired hepatic insulin action. High fat (HF)-fed Glp1r(-/-) mice exhibit…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Targeted inhibition of complement activation prevents features of preeclampsia in mice by Qing, Xiaoping, Redecha, Patricia B., Burmeister, Melissa A., Tomlinson, Stephen, D'Agati, Vivette D., Davisson, Robin L., Salmon, Jane E.

    Published in Kidney international (01-02-2011)
    “…Preeclampsia is a major cause of maternal and neonatal morbidity and mortality. In mouse models, complement activation in the placenta is associated with…”
    Get full text
    Journal Article
  12. 12

    Glucagon-Like Peptide-1 Receptor Knockout Mice Are Protected from High-Fat Diet-Induced Insulin Resistance by Ayala, Julio E, Bracy, Deanna P, James, Freyja D, Burmeister, Melissa A, Wasserman, David H, Drucker, Daniel J

    Published in Endocrinology (Philadelphia) (01-10-2010)
    “…Glucagon-like peptide-1 augments nutrient-stimulated insulin secretion. Chow-fed mice lacking the glucagon-like peptide-1 receptor (Glp1r) exhibit enhanced…”
    Get full text
    Journal Article
  13. 13

    Silencing Nox4 in the Paraventricular Nucleus Improves Myocardial Infarction–Induced Cardiac Dysfunction by Attenuating Sympathoexcitation and Periinfarct Apoptosis by Infanger, David W, Cao, Xian, Butler, Scott D, Burmeister, Melissa A, Zhou, Yi, Stupinski, John A, Sharma, Ram V, Davisson, Robin L

    Published in Circulation research (11-06-2010)
    “…RATIONALE:Myocardial infarction (MI)-induced heart failure is characterized by central nervous system–driven sympathoexcitation and deteriorating cardiac…”
    Get full text
    Journal Article
  14. 14

    Genetic Silencing of Nox2 and Nox4 Reveals Differential Roles of These NADPH Oxidase Homologues in the Vasopressor and Dipsogenic Effects of Brain Angiotensin II by Peterson, Jeffrey R, Burmeister, Melissa A, Tian, Xin, Zhou, Yi, Guruju, Mallikarjuna R, Stupinski, John A, Sharma, Ram V, Davisson, Robin L

    Published in Hypertension (Dallas, Tex. 1979) (01-11-2009)
    “…The renin-angiotensin system exerts a tremendous influence over fluid balance and arterial pressure. Angiotensin II (Ang-II), the effector peptide of the…”
    Get full text
    Journal Article
  15. 15

    Cardiovascular Risk Reduction: A Pharmacotherapeutic Update for Antiplatelet Medications by Smith, Troy J, Johnson, Jessica L, Habtewold, Abiy, Burmeister, Melissa A

    “…This update presents evidence for new antiplatelet therapies including modified P2Y inhibitors and a new class of thromboxane antagonists. Discussed are…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Exendin-4 improves cardiac function in mice overexpressing monocyte chemoattractant protein-1 in cardiomyocytes by Younce, Craig W, Niu, Jianli, Ayala, Jennifer, Burmeister, Melissa A, Smith, Layton H, Kolattukudy, Pappachan, Ayala, Julio E

    “…Abstract The incretin hormone glucagon-like peptide-1 (Glp1) is cardioprotective in models of ischemia-reperfusion injury, myocardial infarction and…”
    Get full text
    Journal Article
  18. 18

    In Vivo Bioluminescence Imaging Reveals Redox-Regulated Activator Protein-1 Activation in Paraventricular Nucleus of Mice With Renovascular Hypertension by Burmeister, Melissa A, Young, Colin N, Braga, Valdir A, Butler, Scott D, Sharma, Ram V, Davisson, Robin L

    Published in Hypertension (Dallas, Tex. 1979) (01-02-2011)
    “…Renovascular hypertension in mice is characterized by an elevation in hypothalamic angiotensin II levels. The paraventricular nucleus (PVN) is a major…”
    Get full text
    Journal Article
  19. 19

    Cardiovascular responses to peripheral chemoreflex activation and comparison of different methods to evaluate baroreflex gain in conscious mice using telemetry by Braga, Valdir A, Burmeister, Melissa A, Sharma, Ram V, Davisson, Robin L

    “…Peripheral chemoreceptors located in the carotid bodies are the primary sensors of systemic hypoxia. Although the pattern of responses elicited by peripheral…”
    Get more information
    Journal Article
  20. 20

    Centrally administered nociceptin/orphanin FQ (N/OFQ) evokes bradycardia, hypotension, and diuresis in mice via activation of central N/OFQ peptide receptors by Burmeister, Melissa A, Kapusta, Daniel R

    “…The present studies examined the cardiovascular and renal responses produced by activation of central nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptors in…”
    Get more information
    Journal Article